Control of MRSA infection and colonisation in an intensive care unit by GeneOhm MRSA assay and culture methods.
BACKGROUND
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major nosocomial pathogens. Due to the diffusion of MRSA strains in both hospital and community settings, prevention and control strategies are receiving increased attention. Approximately 25% to 30% of the population is colonised with S. aureus and 0.2% to 7% with MRSA. The BD GeneOhm MRSA real-time PCR assay offers quicker identification of MRSA-colonised patients than do culture methods.


METHODS
Ninety-five patients admitted to the Intensive Care Unit of IRCCS Policlinico San Matteo of Pavia (Italy) for a period > 24 h were screened for MRSA colonisation with both the culture method and the GeneOhm assay.


RESULTS
Of the 246 nasal swabs collected from 95 patients, 36 samples were found to be positive by both methods (true-positive). 30% of colonised patients had developed the MRSA infection.


CONCLUSIONS
Our results show that the GeneOhm MRSA assay is a valuable diagnostic tool for detecting MRSA quickly in nasal swabs. This study confirms that colonisation represents a high risk factor for MRSA infection, and that good MRSA surveillance in an Intensive Care Unit is therefore an excellent way to prevent MRSA infection.
Dalla Valle
Claudia
C
Laboratorio di Batteriologia e Micologia, Area Infettivologica, Fondazione IRCCS S, Matteo, Pavia, Italia. claudia_dallavalle01@yahoo.it
Pasca
Maria Rosalia
MR
De Vitis
Debora
D
Marzani
Federico Capra
FC
Emmi
Vincenzo
V
Marone
Piero
P
D005188:False Negative Reactions; D005189:False Positive Reactions; D006801:Humans; D017053:Infection Control / Q000379:methods*; D007362:Intensive Care Units; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D009296:Nasal Cavity / Q000382:microbiology; D016133:Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*
J Clin Microbiol. 2004 Dec;42(12):5578-81
15583284
Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):47-53
18663499
Diagn Microbiol Infect Dis. 2005 Jun;52(2):113-22
15964499
J Infect Dis. 2008 May 1;197(9):1217-9
18422431
J Clin Microbiol. 2006 Apr;44(4):1219-23
16597841
Diagn Microbiol Infect Dis. 2009 Feb;63(2):132-9
19081695
Clin Infect Dis. 2004 Sep 15;39(6):776-82
15472807
J Clin Microbiol. 2008 Jan;46(1):350-1
18032616
J Hosp Infect. 2007 Jan;65(1):24-8
17145100
Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):751-4
17684779
J Clin Microbiol. 2006 Aug;44(8):2904-8
16891510
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9
16355321
J Clin Microbiol. 2007 Sep;45(9):2993-8
17626166
J Clin Microbiol. 2000 Jun;38(6):2429-33
10835024
Dis Mon. 2008 Dec;54(12):751-5
18996275
Lancet. 2001 May 26;357(9269):1674-5
11425376
Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):459-66
17541656
Dis Mon. 2008 Dec;54(12):801-6
18996283
J Clin Microbiol. 2008 Feb;46(2):743-6
18057129
J Clin Microbiol. 2007 Aug;45(8):2486-90
17537949